Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies are working hard to make advancements that can help patients. Stem cells ...

On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This week's top technology and ...

Neurodegenerative diseases like Parkinson's and Alzheimer's are characterized by irreversible neuron damage and limited natural repair mechanisms. While stem cell therapy holds great promise for ...

Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic disorders. Now, a clinical trial reports that a single dose can ...

When you were first conceived, you were a single cell. From this basic fact, we can extrapolate a few things, most especially that all the cells that make up your body today came (indirectly) from ...

Earlier this week, San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. If it passes regulatory muster, it ...

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of Crohn’s disease clinical trials.

BEEVILLE, Texas — More than 300 students at St. Mary's Academy Charter School stepped into a whole new world of learning inside the Texas Mobile STEM Laboratory—one of nine high-tech labs traveling ...